Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity
Cell Reports · 2023-06 · 42 (6) · 112613
DOI: 10.1016/j.celrep.2023.112613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-06. Verfasst von Martin Potts und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medicine, University of Cambridge, Cambridge …. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
Certain serum proteins, including C-reactive protein (CRP) and D-dimer, have prognostic value in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nonetheless, these factors are non-specific, providing limited mechanistic insight into the peripheral blood mononuclear cell (PBMC) populations that drive the pathogenesis of severe COVID-19. To identify cellular phenotypes associated with disease, we performed a comprehensive, unbiased analysis of total and plasma-membrane PBMC proteomes from 40 unvaccinated individuals with SARS-CoV-2, spanning the whole disease spectrum. Combined with RNA sequencing (RNA-seq) and flow cytometry from the same donors, we define a comprehensive multi-omic profile for each severity level, revealing that immune-cell dysregulation progresses with increasing disease. The cell-surface proteins CEACAMs1, 6, and 8, CD177, CD63, and CD89 are strongly associated with severe COVID-19, corresponding to the emergence of atypical CD3+CD4+CEACAM1/6/8+CD177+CD63+CD89+ and CD16+CEACAM1/6/8+ mononuclear cells. Utilization of these markers may facilitate real-time patient assessment by flow cytometry and identify immune populations that could be targeted to ameliorate immunopathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
- Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW,…
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
- NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0AW, UK.
- Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 OAW, UK.
- Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Förderung
- Cancer Research UK
- Medical Research Council
- Wellcome Trust
- Department of Health
- NHGRI NIH HHS
- National Human Genome Research Institute
- UCLH Biomedical Research Centre
- Health Data Research UK
Zitieren
APA
Potts, M., Fletcher-Etherington, A., Nightingale, K., Mescia, F., Bergamaschi, L., Calero-Nieto, F. J., Antrobus, R., Williamson, J., Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Parsons, H., Huttlin, E. L., Kingston, N., Göttgens, B., Bradley, J. R., Lehner, P. J., Matheson, N. J., Smith, K. G. C., Wills, M. R., Lyons, P. A., & Weekes, M. P. (2023). Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity. Cell Reports, 42(6), 112613. https://doi.org/10.1016/j.celrep.2023.112613
Vancouver
Potts M, Fletcher-Etherington A, Nightingale K, Mescia F, Bergamaschi L, Calero-Nieto FJ, et al. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity. Cell Reports. 2023;42(6):112613. doi:10.1016/j.celrep.2023.112613
BibTeX
@article{Potts2023,
author = {Potts, Martin and Fletcher-Etherington, Alice and Nightingale, Katie and Mescia, Federica and Bergamaschi, Laura and Calero-Nieto, Fernando J and Antrobus, Robin and Williamson, James and Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration and Parsons, Harriet and Huttlin, Edward L and Kingston, Nathalie and Göttgens, Berthold and Bradley, John R and Lehner, Paul J and Matheson, Nicholas J and Smith, Kenneth G C and Wills, Mark R and Lyons, Paul A and Weekes, Michael P},
title = {Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {6},
pages = {112613},
doi = {10.1016/j.celrep.2023.112613}
}
EUVIMED